Nal Von Minden

Country/Region: Germany     State/Province: Berlin

Main Products: Rapid Tests

Company Introduction
We, at nal von minden GmbH, are sales professionals, specialising in vitro diagnostic products for the European market. In the field of drug analysis and medical diagnosis, we provide a comprehensive and innovative range of products of the highest quality.Our current portfolio includes rapid tests and ELISA tests for the areas of pediatrics, gynecology, urology, infectious diseases, bacteriology, serology and toxicology. Laboratory confirmation is also a service we can offer our partners.We have experienced onsite specialists who are available to answer any questions you may have: from product development and technical support to quality assurance.For over 30 years we have been caring for our customers as a company. Our long-term experience and know-how with products for laboratories, in-vitro diagnostics and analytics enables us to offer products that meet the exact demands of our customers.In the year 2008 nal24 GmbH from Regensburg and the von Minden GmbH from Moers merged and from then on nal von minden GmbH was formed. This successful merger enabled an enhancement of the previous business activities on the European market and by using synergies can offer advantages to our customers through the expansion of in vitro diagnostics sales and greater efficiency.Our marketing and sales team is divided between the main sites of Regensburg (Germany), Moers (Germany) and Den Haag (Netherlands). Our products are tested in our logistics center in Moers, before being sent from here on to our customers across Europe. We also have a Marketing and Sales Team dedicated solely for the UK and Ireland Market, with our native English speaking team available to answer any questions you may have.
Company Overview

Business Type: Manufacturer, Retailer

Year Established: 1983

Employees: Above 1000 People

Plant Area: 30,000-50,000 square meters

Business Information

Main Markets: South America 9% Africa 8% Eastern Asia 12% Domestic Market 11% North America 10% Eastern Europe 8% Southern Europe 12% Mid East 11% Northern Europe 12% Oceania 7%

Trade Capacity: FOB, FCA, DAF

Contract Manufacturing: OEM Service Offered

Nearest Port: Germany

Trade & Financial Information

Annual Revenue: US$5 Million - US$10 Million

Total Revenue: US$1 Million - US$2.5 Million

Export Revenue: US$10 Million - US$50 Million

Annual Output: US$50 Million - US$100 Million

Registered Capital: US$50 Million - US$100 Million

Export Percentage: 71% - 80%

Payment Modes: USD, AUD, CHF

Lead Time: 34 days

Import/Export Mode: Using an agent

Product Showcase
Rapid Tests

CL-Link > Health & Medicines in Germany Health & Medicines in Berlin Medical Consumable in Germany Medical Consumable in Berlin Face Mask in Germany Face Mask in Berlin